Cardiac transient outward potassium current channel (Ito)

The cardiac transient outward potassium current channel is a voltage-gated ion channel complex responsible for the Ito current, which initiates the early rapid repolarization (Phase 1) of the cardiac action potential. This current is a primary determinant of the action potential notch and influences the height and duration of the plateau phase, thereby regulating calcium influx and cardiac contractility (Source: StatPearls, Cardiac Electrophysiology, 2023). The channel is primarily composed of alpha subunits Kv4.3 (encoded by KCND3) or Kv4.2 (encoded by KCND2), often associated with regulatory subunits such as KChIP2 (Source: UniProt, P51788). Alterations in Ito density or kinetics are implicated in various cardiovascular diseases; for instance, a reduction in Ito is a hallmark of electrical remodeling in heart failure and hypertrophy (Source: PubMed, PMID: 15103334). Conversely, gain-of-function mutations in the underlying subunits are associated with Brugada syndrome and short QT syndrome (Source: PubMed, PMID: 15103334). Pharmacological inhibitors of Ito, such as vernakalant, are used clinically to treat atrial fibrillation by prolonging the atrial refractory period (Source: PMC2842940). Other drugs like quinidine and flecainide also exhibit inhibitory effects on this channel, contributing to their anti-arrhythmic profiles (Source: PubMed, PMID: 11854014). However, therapeutic targeting is challenging because excessive inhibition or activation can lead to life-threatening ventricular arrhythmias or conduction abnormalities (Source: PubMed, PMID: 11854014). Research continues to focus on subunit-specific modulators to minimize off-target effects on other cardiac currents. Overall, these channels are vital for maintaining the electrical stability and rhythmic contraction of the heart.

Other names

Transient outward potassium currentItoKv4.3Kv4.2KCND3KCND2Voltage-gated potassium channel subunit alpha 4.3Potassium voltage-gated channel subfamily D member 3

Inhibition of the transient outward potassium current (Ito) to prolong the early phase of repolarization (Phase 1) and increase the atrial effective refractory period.